Enovis ENOV
NYSE ENOV
$18.68 -0.34 (-1.79%)
As of: Sep 10, 2026 · 9:58 AM EDT

Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026)

Enovis' (ENOV) quarterly Liabilities and Shareholders Equity came in at $3.8 billion in Q3 2026, down 25.0% year-over-year from $5.0 billion in Q3 2025, and down 1.73% quarter-over-quarter from $3.8 billion in Q2 2026.

Analysis

Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $3.8 billion the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 25.0% year-over-year to $3.8 billion in Q3 2026; TTM through Jul 2026 was $15.9 billion, a 21.32% decrease from a year earlier, with the FY2025 full-year figure at $3.8 billion, down 18.73% from the prior year.
  • Liabilities and Shareholders Equity was $3.8 billion for Q3 2026 at Enovis, down from $3.8 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $8.5 billion in Q2 2022 and troughed at $3.8 billion in Q3 2026.
  • A 5-year average of $4.8 billion and a median of $4.5 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 49.82% in 2022 and rose 27.42% in 2024, its largest moves.
  • Over 5 years, Liabilities and Shareholders Equity stood at $4.3 billion in 2022, then increased by 5.52% to $4.5 billion in 2023, then climbed by 4.64% to $4.7 billion in 2024, then fell by 18.73% to $3.8 billion in 2025, then fell by 1.79% to $3.8 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $3.8 billion (Q3 2026), $3.8 billion (Q2 2026), and $3.8 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 182.70 Bn 177.10 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 126.56 Bn 121.34 Bn 1.96 Bn 20.88 Bn
3 Medtronic 118.15 Bn 109.33 Bn 6.34 Bn 93.31 Bn
4 Stryker 104.94 Bn 101.46 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 64.79 Bn 64.25 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.87 Bn 45.62 Bn 1.35 Bn 13.87 Bn
7 Alcon 33.04 Bn 31.59 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.07 Bn 30.13 Bn 830.00 Mn 6.46 Bn
9 Steris 20.78 Bn 20.29 Bn 684.20 Mn 10.74 Bn
10 Enovis 1.08 Bn 1.07 Bn 359.25 Mn 3.77 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 3.77 Bn
Apr 3, 2026 3.83 Bn
Dec 31, 2025 3.83 Bn
Oct 3, 2025 4.43 Bn
Jul 4, 2025 5.02 Bn
Apr 4, 2025 4.88 Bn
Dec 31, 2024 4.72 Bn
Sep 27, 2024 5.55 Bn
Jun 28, 2024 5.44 Bn
Mar 29, 2024 5.48 Bn
Dec 31, 2023 4.51 Bn
Sep 29, 2023 4.40 Bn
Jun 30, 2023 4.44 Bn
Mar 31, 2023 4.30 Bn
Dec 31, 2022 4.27 Bn
Sep 30, 2022 4.44 Bn
Jul 1, 2022 4.50 Bn
Apr 1, 2022 8.48 Bn
Dec 31, 2021 8.52 Bn
Oct 1, 2021 7.97 Bn